Human immunodeficiency virus (HIV)-1 -infected children
delineate the relationship between virus load and disease course in children [17 -20] . manifest variable disease patterns. As many as 20% -30% of perinatally infected children develop an AIDS-defining illness Several investigators have shown that HIV RNA levels are extremely high during infancy and early childhood compared or die by their second birthday; however, the majority of children live significantly longer, sometimes into their second dewith levels measured in adults [17 -19, 21] . De Rossi et al. [18] described a relationship between the pattern of viral replication cade [1 -4] .
Many factors have been proposed to explain the variability early in life and disease outcome in a small cohort of HIV-1 -infected children. Similarly, data from a large perinatal cohort, of disease manifestations, including timing of transmission [5, 6] , maternal health status [7] , maternal virus load at delivery the Women and Infants Transmission Study (WITS) [19] , show a strong association between high HIV RNA virus load during [8], gestational age [9] , genetic susceptibility [10] , and intrinsic characteristics of the virus [11] . For HIV-1 -infected adults, a early infancy and poor clinical outcome. Mofenson et al. [20] described an independent association of CD4 lymphocyte perrelationship between the HIV-1 RNA virus load and disease progression has been described [12 -16] . Similarly, data from centage and RNA level with mortality risk in a cohort of HIV-1 -infected children enrolled in an efficacy trial of intravenous a number of studies of infants and children are beginning to immunoglobulin. And Palumbo et al. [17] , analyzing data from a large pediatric antiretroviral trial, have shown a strong association between disease progression and baseline RNA levels therapy, which may affect virus load or disease progression, Informed consent was obtained from all study participants, according to the was not controlled in these analyses. sent data from a cohort of 86 HIV-1 -infected children who
The use of trade names is for identification only and does not imply endorsewere not exposed to zidovudine prophylaxis for the prevention ment by the Public Health Service or the US Department of Health and Human Services.
of perinatal transmission; we used only blood samples drawn progression at eight New York City health care institutions. ProtoFor analysis, virus load results were grouped by the child's age at phlebotomy as follows: 0-6 days, 7-30 days, 2-3 months, 4-col design for the larger study has been described elsewhere [22] . Evaluations of pregnant and postpartum women included a detailed 6 months, 7-9 months, 10-12 months, 13-24 months, 25-36 months, and 37-48 months. Children who received postnatal antiquestionnaire, periodic physical examinations, disease staging, and phlebotomy. Infants were scheduled for evaluation at delivery, retroviral prophylaxis to prevent perinatal transmission were excluded from analysis; virus load results corresponding to samples every 2-3 months during the first 18 months of life, and every 6 months thereafter. During each of these visits, a physical examinataken after the initiation of antiretroviral treatment were also excluded. However, in situations in which antiretroviral therapy was tion and phlebotomy were conducted and a medical history was obtained. Hospitalizations, relevant diagnoses, and medications introduced after a virus load sample but before an outcome of interest, antiretroviral use was considered as a covariate in the were recorded by study physicians or obtained retrospectively by chart abstraction. Gestational age at birth was determined by the analysis (see below). Differences between children whose observations were used in Ballard method.
Determination [23] . In no case was CDC-C classification assigned
To make maximum use of available data, point estimates and 95% confidence intervals (CIs) of geometric mean virus load by based solely on the presence of a presumptive AIDS-defining illness. Either AIDS or HIV disease was determined to be a signifiage were derived by use of generalized estimating equations [26] : Virus load measurements to the end of year 3 of life were subjected cant underlying factor in all deaths occurring to date in this cohort.
Women were classified as having had AIDS at delivery if they to a single longitudinal regression analysis, using indicator variables representing the above age groups as predictors of log virus met the criteria of the 1993 Centers for Disease Control revised classification system [24] . Maternal CD4 cell count values used
load. An exchangeable within-subject correlation structure was assumed in results reported here, although other structures proin analyses were those of the last observation in the third trimester of pregnancy or within 2 weeks postpartum.
duced similar results. CIs were constructed from parameter estimates and their respective SEs by use of the usual large-sample Laboratory testing. Routine laboratory testing of infant blood samples included a determination of lymphocyte subsets by flow method. These values were then exponentiated to yield results in virus load units. cytometry and of HIV antibody by ELISA and Western blot assay, done at the New York City Department of Health, Bureau of Virus load was then correlated with progression to AIDS (CDC-C classification) or to a surrogate end point, severe immunosupLaboratories. The earliest available infant blood specimens were assayed for the presence of HIV proviral DNA by polymerase pression (CDC-3). Children who died but did not reach the end point of interest were treated as if they had reached that end point, chain reaction (PCR) [25] .
Blood for virus load studies was collected in standard heparinbecause all deaths were attributable to HIV and were thus thought to represent an outcome of interest. To assess the association beized vacuum tubes (Becton Dickinson, Rutherford, NJ) and delivered by overnight courier at ambient temperatures to CDC, where tween virus load at any particular age and hazard of imminent progression to these end points, proportional hazards models were peripheral blood mononuclear cells were separated by ficoll-hypaque centrifugation on arrival. Plasma supernatant was aliquoted constructed that used as a predictor of each outcome all virus load measurements beyond week 1 of life in a time-dependent manner, into radiation-sterilized cryogenic vials (Sarstedt, Newton, NC) and stored at 070ЊC. Total time from phlebotomy to freezing was so that the risk ratio (RR) of log virus load at any particular age was assumed to be a function of the value of log virus load at 24-30 h. Testing was retrospectively done in batches of these stored samples. Plasma HIV RNA was measured with the nucleic the immediately preceding measurement. In all such analyses, the occurrence of any antiretroviral treatment between time of virus acid sequence-based amplification (NASBA) HIV RNA QT kit (Organon Teknika, Durham, NC), an isothermal nucleic acid amload measurement and end point (or date last seen) was added as an additional time-dependent dichotomous covariate. It was plification assay that has been adapted for use with HIV. The assay was done according to the manufacturer's specifications by assumed that once antiretroviral treatment was initiated, it continued without interruption, so that the entire period between antiretpersonnel blinded to the progression status of the children. The NASBA QT system estimates the amount of RNA in the original roviral onset and the outcome of interest was therefore considered ''treated.'' The addition of age-by-log virus load interaction terms sample on the basis of data generated from native RNA and three synthetic internal RNA calibrators. The assay threshold of sensitivto such models indicated that in most cases the proportional hazards assumption did not hold; for this reason, interaction terms of ity is 1000 RNA copies/mL when 100 mL is used as an input volume of plasma.
log virus load with indicator variables representing 6-monthly age groups were used to allow estimation of log virus load RRs sepaStatistical methods. For both biologic and statistical reasons, virus load scores were transformed to base 10 logarithms before rately for different age groups in a single analysis. Overall significance of association of log virus load with outcome was assessed analysis. Virus load results below the assay's sensitivity threshold of 10 3 copies/mL were assigned the value of 999. The impact of with likelihood ratio tests that compared a model containing these log virus load-by-age group terms plus an antiretroviral treatment this technique was investigated by rerunning analyses twice, with subthreshold observations reassigned to the value 500 and to a term with a model containing only the antiretroviral term. RR estimates are reported here only for 6-monthly age groups having random number between 1 and 999; no substantial differences were noted between results generated by the three methods. a sufficient number of outcome events to make such estimates study's other HIV-infected children revealed some differences † Estimated from Kaplan-Meier analysis.
(table 1). Selected children were less likely to be premature, ‡ Log-rank test of complete survival.
were less likely to test PCR-positive during the first week of § Wilcoxon test.
life, and had older mothers. Nineteen (21%) of the 89 selected children have died; the median age at death among these 19
RNA Virus Load Characteristics
was 355 days (range, 29 -1404). Median follow-up time among the 70 still-living children was 1100 days (range, 45 -3117). Characteristics of the 313 virus load observations are listed in table 2. Nine of the 89 infants had blood samples available Twenty-seven (30%) of the 89 have progressed to CDC-C classification, with the following earliest AIDS-defining diagnowithin 48 h of birth. Only 1 of these infants tested PCR-positive during that time; virus load at this observation was 1.5 1 10 5 ses: HIV encephalopathy (9), Pneumocystis carinii pneumonia (8), recurrent bacterial infections (5), esophageal candidiasis (3), copies/mL. One infant who tested PCR-negative had detectable virus load (3.2 1 10 5 copies/mL) in the corresponding plasma wasting syndrome (1), and disseminated herpes simplex (1). Median age at first CDC-C classification among these children was sample from the same blood draw. Twenty-two (25%) of 89 infants had virus load measure-271 days (range, 46-1403); 14 of the 27 have died. Five other children have died without reaching class CDC-C; causes of death ments during the first week of life. Seventeen (77%) of these were below the NASBA detection threshold of 10 3 copies/mL. were sepsis (2), pneumonia (2), and end-stage HIV disease with HIV-associated congestive cardiomyopathy (1) .
The other 5 values ranged from 1.5 1 10 5 to 1.7 1 10 6 . Only 13 (4%) of the remaining 291 samples obtained beyond the Forty-three (48%) of the 89 have progressed to CDC-3 classification, at median age 303 days (range, 1 -1490). Six other first week of life were subthreshold, and all but 4 of these occurred within the first 3 months. Geometric mean virus load children have died without progressing to that end point.
Sixty-three (71%) of the 89 children received antiretroviral increased to a high level of 7.9 1 10 5 by the end of the first month of life and remained above 6.0 1 10 5 until months 7 -treatment during the course of study, including zidovudine, zalcitabine, didanosine, stavudine, and lamivudine. No children 9, then declined somewhat to 2.1 1 10 5 during months 12 -24 ( figure 1) . The maximum value among the 5 virus load were treated with protease or nonnucleoside reverse transcriptase inhibitors during the observation period.
samples obtained between months 36 and 48 was 2.4 1 10 5 .
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Virus Load and Disease Progression
vals were therefore estimated simultaneously; insufficient data prevented meaningful estimates beyond 18 months of life. The We sought to determine the correlation of plasma virus load prognostic value of month 2 and 3 virus load scores apparently measured in two ways -during the earliest stages of infection diminishes with increasing age of the child. The association of (birth to 3 months) and throughout the observation periodvirus load in this window with progression to CDC-3 classifiwith disease progression. cation or death did not reach statistical significance (table 3) .
Predictive ability of virus load measured from birth to 3
Association between virus load and immediate hazard of months of life. Most virus load results in days 0 -6 of life progression. Throughout infancy, vulnerability to both HIV were subthreshold and had no ability to predict disease progresdisease end points was strongly associated with the most recent sion. Eight (47%) of the 17 children with undetected RNA in prior virus load measurement, even after adjusting for maternal the first week of life progressed to CDC-C classification or AIDS and gestational age. RRs were estimated separately for death; only 1 of 5 children with detectable RNA (virus load, different age ranges (table 4) . Again, the strength of association 4.2 1 10 5 copies/mL) progressed to CDC-C classification or appears to diminish as the child grows older. Kaplan-Meier death (at 162 days of age), while the other 4 had not reached and linear regression techniques were used to show that the this end point when last seen (at 290, 833, 889, and 1188 days children who had information on both covariates did not differ of age) (log-rank test, P Å .414).
significantly from the ones who did not, in terms of time to Controlling for use of antiretroviral therapy after virus load progression to CDC-C classification or death or to CDC-3 measurement and using the earliest virus load determination classification or death, or in earliest log virus load score controlduring days 7 -30 of life, we found no significant ability of ling for age. virus load to predict progression to CDC-C classification or death. However, we found that virus load was predictive in this early period of subsequent progression to CDC-3 classifiDiscussion cation or death (P Å .042, n Å 31). The RR for a 1-log increase in virus load was estimated at 1.6 (95% CI, 1.0 -2.6); after
In this study of perinatally HIV-1 -infected children unexposed to peripartum zidovudine prophylaxis who were followed controlling for prematurity and maternal AIDS covariates, RR was 1.4 (95% CI, 0.8 -2.5; n Å 26).
from birth, we found that RNA virus load attained a very high level within the first few weeks of life, was sustained at these Controlling for antiretroviral use after virus load measurement, the earliest virus load determination within months 2 -high levels throughout the third year, and was highly associated with disease progression. 3 (median age, 55 days) was a highly significant predictor of progression to CDC-C classification or death during the period The virus load levels described here are 1 -2 logs greater than reported in adults during seroconversion or the early latent of observation. In this analysis, however, an overall risk estimate could not be determined because the RR was not constant period after primary infection [12 -16] . The high levels reached by 2 months of age among the children reported here were with age. Separate RRs corresponding to 6-monthly age inter- nearly 4-fold greater than the peak reported within the first antiretroviral treatment were excluded from the determination of geometric means, and we believe that the values presented month after seroconversion in adults [27, 28] . Furthermore, virus load stabilized at Ç7 1 10 5 copies/mL at 2 months in in figure 1 provide an accurate depiction of HIV-1 RNA production in this untreated cohort of infants and children. the infants and remained fairly constant for the subsequent 9 -12 months. This is in comparison to adults immediately after Perhaps the most important determinant of the sustained high viral replication during early vertical infection is the presence seroconversion, in whom HIV RNA levels rapidly fall by Ç1 log within 30 days of the peak value and continue to decline of high levels of target CD4 cells [29, 32] . At birth, absolute CD4 cell counts are high, and their decline over time approxiduring the subsequent months. The burst of viral replication in adults following primary infection is believed to be the result mately parallels the decline in virus load during the first several years of life. A predator-prey model between virus and target of unopposed viral replication in the setting of a naive immune response. The reasons for the high and sustained levels of viral CD4 cells has been proposed to explain viral dynamics in adults [33] and may apply to infants as well. In this model, the level RNA in perinatally infected infants remain to be determined but may be a combination of the immaturity of the infant of viral replication (predator) is determined by the amount of target CD4-bearing cells in which HIV can replicate (prey). immune system, increased numbers of available target CD4 cells [29] during the first months of life within which virus This model would explain viral dynamics in early adult infection but would not explain the substantial rise seen in virus production occurs, and/or the potential rapid replenishment of target cells in the developing infant.
load at the terminal stages of disease when circulating CD4 cells are markedly diminished. This model would also explain The gradual decrease in high virus load levels during late infancy and early childhood shown here and by others may be the sustained high levels of viremia in HIV-infected infants and their subsequent slow decline. a result of attrition due to early death of infants with rapidly progressive disease, who are most likely to have highest virus Our finding that virus load as early as the first month of life predicts HIV progression suggests that the disease outcome is load [17 -20, 30] . However, we did see a similar decrease in virus loads during the same period among the children who determined early in the course of HIV infection. Data from a small cohort studied by De Rossi et al. [18] support this finding. did not develop rapidly progressive disease (data not shown), suggesting that there is delayed control of viral replication. This These authors describe three distinct patterns of viral replication during the first weeks of life, one of which indicated that may account for the poor survival of infants with perinatally acquired HIV infection compared with infection acquired in infants who had an early, rapid, and large increase in virus load that was sustained through 2 -3 months of age had a adulthood [31] . Samples taken while children were receiving / 9d4a$$jy20 05-15-98 11:54:03 jinfa UC: J Infect poor clinical outcome compared with those who had significant HIV-1 RNA levels, CD4 lymphocyte percentage, and mortality among older HIV-1 -infected children enrolled in an intravedecline after the initial burst of viral replication. Similarly, studies in adults show that the extent of decline after the initial nous immunoglobulin prophylaxis trial. In this study, both baseline RNA level and CD4 lymphocyte percentage at entry burst of replication during the period of seroconversion is correlated with the rate of disease progression [12, 16] .
were predictive of mortality risk. Children participating in the treatment study were generally older (mean, 3.4 years) than Data from the WITS cohort [19] show that infants with high virus loads during the first months of life are at increased risk those we studied. Our data, along with those of the WITS and intravenous immunoglobulin studies, indicate that virus load for progression. In addition to supporting the results of the WITS analysis, our data show that virus load during months in infants and children, as in adults, is strongly associated with disease progression. 2 -3 of life is also highly predictive of progression to CDC-C classification or death. A 1-log increase in virus load during
We also found a 3-to 4-fold increase in the risk of clinical and immunologic progression associated with each 1-log inthis interval resulted in an 11 times greater risk of disease progression or death by 6 months of life. Furthermore, virus crease in most recent virus load measurement any time during the first 12 months of life. These data demonstrate a direct and load during days 7 -30 was found to be predictive of progression to CDC-3 category or death: A 1-log increase resulted in continuous relationship between HIV-1 RNA levels and the risk of progression in young children. Similar to findings in a modest 1.6 times greater risk of immunologic deterioration and death. Our results also complement the findings of Moadults, virus load obtained throughout infancy appears to be both predictive of disease progression and highly associated fensen et al. [20] , who reported on the association between Our data suggest that the pattern of disease for HIV-1 -during the first week of life were below the level of detection for this assay. While these undetectable values may represent infected children may be determined during the first weeks of life. We are hopeful that the initiation of aggressive antiretrovilow levels of virus, which could not be measured with our assay, we believe that these findings suggest that perinatal ral therapy during this crucial time period will effectively reduce virus burden and significantly alter the natural history infection in most of these infants occurred during the intrapartum period. Furthermore, our data show that this period of of this disease in children. Out data suggest that aggressive antiretroviral therapy of infants and young children may imundetectable virus load is short and is followed by a significant and sustained production of virus. This brief period during the prove their clinical course. first days and weeks of life before viral replication is firmly established may provide a unique opportunity during which cation for perinatal prophylaxis or treatment before sampling were excluded because we believe that HIV RNA levels might be altered by these therapies. The excluded children were sig-
